NeuroPace, Inc. (NPCE)
18.46
-0.83
(-4.30%)
USD |
NASDAQ |
May 08, 16:00
18.38
-0.08
(-0.43%)
After-Hours: 20:00
NeuroPace Research and Development Expense (Annual) : 27.89M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Sight Sciences, Inc. | 14.61M |
| Zomedica Corp. | 7.166M |
| LENSAR, Inc. | 5.622M |
| Intelligent Bio Solutions, Inc. | 2.396M |
| Butterfly Network, Inc. | 36.26M |